RXRX
$4.39
Recursion Pharmaceuticals Inc Cl A
RXRX
Earnings Whisper ®
N/A
2nd Quarter June 2025
Consensus: ($0.36)
Revenue: $17.03 Mil
Latest EPS
Monday, May 5, 2025
What do you expect when RXRX reports earnings?
Where is RXRX's stock price going from here?
Analysts
Pivots
Resistance
$4.90
$4.80
$4.59
Support
$4.28
$4.18
$3.97
Description
Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.
